Winter 2012 - Plasma

HealthWell Foundation Launches SLE Fund

The HealthWell Foundation, a nonprofit organization providing financial assistance to insured patients facing a variety of chronic and life-altering illnesses, has launched a new fund to support treatment of systemic lupus erythematosus (SLE), the most common form of lupus. The fund provides copayment assistance to people who are living with SLE who cannot afford the high-cost medication. “Critical to taking advantage of the latest therapeutic option for any disease is the ability to afford that option,” said HealthWell Foundation President Mary P. Sundeen. “As a direct result of the generosity of our donors, the HealthWell Foundation stands ready to reduce the cost-sharing obligations that many insured patients face when trying to access gold-standard and recently approved medications.” Application information for the SLE fund, as well as information on making a financial donation to support this and other funds, can be found at www.HealthWellFoundation.org.

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.